| Issue Date | Title | Author(s) |
| 2020 | Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database | Cui, Bin; Dong, Zhaohui; Zhao, Mengmeng; Li, Shanshan; Xiao, Hua; Liu, Zhitao; Yan, Xiaowei |
| 2018 | ANALYSIS OF TREATMENT ADHERANCE TO ANTIHYPERTENSIVE DRUGS IN CHINESE HYPERTENSIVE PATIENTS: A RETROSPECTIVE ANALYSIS USING NATIONAL MEDICAL INSURANCE DATABASE | Yan, Xiaowei; Bin, Cui; Dong, Chaohui; Li, Shanshan; Xiao, Hua; Zhao, Mengmeng |
| 2019 | Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy | Yan, Xiaowei; Li, Yong; Dong, Yugang; Wu, Yanhua; Li, Jihu; Bian, Rui; Hu, Dayi |
| 2018 | CHARACTERISTICS, HEALTH RESOURCE UTILIZATION AND MEDICAL EXPENDITURE OF PATIENTS WITH HYPERTENSION AMONG CHINA BASIC MEDICAL INSURANCE PARTICIPANTS IN 2014 | Cui, Bin; Yan, Xiaowei; Dong, Chaohui; Wu, Jingjing; Zhao, Mengmeng |
| 2019 | China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III) | Huo, Yong; Gu, Ye; Ma, Genshan; Guo, Jincheng; Xiong, Longgen; Luo, Zhurong; Xie, Jianhong; Li, Weimin; Zhao, Jianrong; Yan, Xiaowei; Liu, Wei; Xu, Yawei; Bao, Xiaomei; Zhao, Luosha; Yang, Ming; Wang, Bei; Yan, Xiaowei; Guo, Jincheng; Ma, Changsheng; Wang, Mingsheng; Ding, Shenghua; Du, Xinping; Lin, Shan; Cong, Hongliang; Li, Weimin; Dong, Yumei; Gu, Ye; Chen, De; Ruan, Changwu; Zhao, Jianrong; Feng, Liuliu; Bao, Xiaomei; Mao, Wei; Xie, Jianhong; He, Qiang; Wang, Ningfu; Wu, Wei; Xiong, Longgen; Luo, Zhurong; Zhao, Luosha; Ma, Genshan; Xu, Yawei; Wang, Jiguang; Feng, Yinqing; Xie, Liangdi; Li, Nanfang; Li, Xinli; Chen, Luyuan; Wang, Wen; Zhu, Dingliang; Zhang, Xinhua; Yu, Jinming; Sun, Ningling; Zhang, Weizhong |
| 20-Dec-2024 | Clinical practice guideline for the management of hypertension in China | Cai, Jun; Chen, Yaolong; Gao, Runlin; Hu, Dayi; Han, Yaling; Ge, Junbo; Zhang, Yun; Ma, Changsheng; Hui, Rutai; Zhao, Lianyou; Bu, Peili; Ma, Wenjun; Wang, Mei; Bian, Jin; Yin, Xinhua; Lu, Xinzheng; Tian, Gang; Feng, Yingqing; Ren, Ming; Hua, Qi; Liu, Quan; Liu, Kejun; Liu, Lihong; Liu, Min; Liu, Wei; Sun, Gang; Sun, Yingxian; Mou, Jianjun; Yan, Xiaowei; Li, Yuming; Li, Qifu; Li, Yongjun; Li, Nanfang; Li, Yong; Li, Ping; Yang, Jinfeng; Yang, Yanmin; Wu, Shouling; Wu, Zhong; Wu, Hao; Wu, Haiying; Yu, Jing; Wang, Daowen; Song, Lei; Zhang, Hongwei; Zhang, Huimin; Chen, Youren; Chen, Fang; Chen, Xiaoping; Yue, Weihua; Zhou, Birong; Zhao, Dong; Zhao, Qiuping; Zhao, Xiaolong; Yu, Wei; Jiang, Yinong; Zhu, Zhiming; Yao, Lan; Yuan, Hong; Xu, Xinjuan; Guo, Zihong; Guo, Yifang; Tao, Jun; Huang, Jing; Cui, Zhaoqiang; Jiang, Shaobo; Jiang, Xiongjing; Han, Qinghua; Zeng, Chunyu; Xie, Liangdi; Cai, Guangyan; Shan, Ying; Ma, Qingfeng; Wang, Zijun; Wang, Lu; Shen, Quan; Shi, Qianling; Bian, Bo; Xing, Aijun; Ren, Jie; Ren, Mengjuan; Liu, Yunlan; Liu, Kai; Liu, Xiao; Liu, Hui; Qi, Yue; Sun, Runmin; Sun, Yajia; Sun, Yaoyao; Su, Renfeng; Su, Jinzi; Du, Xin; Li, Shicheng; Li, Zhao; Yang, Ning; Yang, Yaling; Yang, Lirui; Yang, Xiaomin; Yang, Nan; Wu, Shouyuan; Zou, Yubao; Song, Wei; Zhang, Tao; Lu, Yao; Chen, Zuoquan; Chen, Gailing; Fan, Chaoqun; Zhou, Xiaoyang; Zheng, Ying; Zhao, Junxian; Hu, Jinbo; Hou, Tianchun; Lou, Ying; Yao, Lixia; Suo, Ning; Jia, Ainan; Xia, Wenhao; Guo, Qiangqiang; Huang, Zhengrong; Peng, Qiang; Lei, Ruobing; He, Lianman; Wang, Tzung-Dau; Yang, Xinchun; Chen, Hong |
| 2017 | Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study | Ding, Rongjing; Ye, Ping; Zhao, Shuiping; Zhao, Dong; Yan, Xiaowei; Dong, Yugang; Li, Jihu; Ran, Yuqin; Hu, Dayi |
| 2013 | Effects and cost-effectiveness of a guideline-oriented primary healthcare hypertension management program in Beijing, China: results from a 1-year controlled trial | Wang, Xin; Li, Weiqin; Li, Xian; An, Ning; Chen, Hao; Jan, Stephen; Ming, Guanghua; Hua, Qi; Yan, Xiaowei; Sun, Ningling; Zhao, Dong; Wu, Yangfeng |
| 2015 | Expert panel of the Chinese Society of Cardiology recommendations on beta-blocker therapy in patients undergoing non-cardiac surgery | Huo, Yong; Shi, Zhongwei; Chen, Yundai; Dong, Yugang; Ge, Junbo; Han, Yaling; He, Ben; He, Zhaochu; Huang, Dejia; Li, Xiaoying; Li, Yong; Liao, Yuhua; Liu, Meilin; Lu, Xinzheng; Ma, Changsheng; Ning, Tianhai; Sun, Ningling; Wang, Jian'an; Wu, Xuesi; Yan, Xiaowei; Yang, Tianlun; Yang, Xinchun; Zhang, Jian; Zhou, Lejin; Zhu, Wenling |
| 2016 | Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China | Lin, Xue; Xu, RuiYi; Fang, Ligang; Chen, Wei; Hu, Dayi; Zhao, Shuiping; Wang, Yongjun; Li, Jihu; Yan, Xiaowei |
| 2014 | Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: Subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China) | Wang, Fan; Ye, Ping; Hu, Dayi; Min, Ying; Zhao, Shuiping; Wang, Yongjun; Mu, Yiming; Yan, Xiaowei; Li, Zhanquan; Wei, Yidong; Li, Jihu |
| 2014 | Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS) | Zhao, Shuiping; Wang, Yongjun; Mu, Yiming; Yu, Bilian; Ye, Ping; Yan, Xiaowei; Li, Zhanquan; Wei, Yidong; Ambegaonakr, Baishaili M.; Hu, Dayi |
